PASKALIUM Drug Patent Profile
✉ Email this page to a colleague
When do Paskalium patents expire, and what generic alternatives are available?
Paskalium is a drug marketed by Glenwood and is included in one NDA.
The generic ingredient in PASKALIUM is potassium aminosalicylate. There are two hundred and forty drug master file entries for this compound. Additional details are available on the potassium aminosalicylate profile page.
Summary for PASKALIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PASKALIUM at DailyMed |
US Patents and Regulatory Information for PASKALIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenwood | PASKALIUM | potassium aminosalicylate | CAPSULE;ORAL | 009395-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenwood | PASKALIUM | potassium aminosalicylate | TABLET;ORAL | 009395-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |